Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris Y Sheng

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Expert Opinion on Biological Therapy|June 8, 2019
Immunotherapy for renal cell carcinomaIris Y Sheng, Brian I Rini
Cancer Management and Research|July 2, 2020
Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to DateIris Y Sheng, Moshe C Ornstein
Journal of Hematology|April 18, 2020
Infiltrative Rash Secondary to Leukemic-Phase Diffuse Large B-Cell Lymphoma With t(14;18), CDKN2A and MLL DeletionIris Y Sheng, Diana O Treaba, Kenneth D Bishop
Drugs in Context|April 2, 2021
Volume matters and intensification is needed: emerging trends in the management of advanced prostate cancerIris Y Sheng, Pedro Barata, Raafat Alameddine, et al.
Expert Review of Anticancer Therapy|June 9, 2020
Non-metastatic castration-resistant prostate cancer: current status and future directionsRuby Gupta, Iris Y Sheng, Pedro C Barata, et al.
Case Reports in Oncological Medicine|July 9, 2019
Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)Iris Y Sheng, Megan Kruse, Kathryn M Leininger, et al.
The Oncologist|October 1, 2025
A single-institution study evaluating the fertility of young adults with malignancy treated with immunotherapyJenny D Gong, Kathryn Coyne, Matthew Mirsky, et al.
Drugs in Context|June 29, 2026
Perioperative immune-checkpoint inhibitors for muscle-invasive bladder cancerAlbert Jang, Abby L Grier, Iris Y Sheng, et al.
Journal of Pediatric Ophthalmology and Strabismus|July 15, 2014
Feasibility of retinal screening in a pediatric population with type 1 diabetes mellitusAnton M Kolomeyer, Natasha V Nayak, Melissa A Simon, et al.
Clinical Genitourinary Cancer|August 18, 2020
Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage MigrationIris Y Sheng, Wei Wei, Yu-Wei Chen, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Expert Opinion on Biological Therapy|June 8, 2019
Immunotherapy for renal cell carcinomaIris Y Sheng, Brian I Rini
Cancer Management and Research|July 2, 2020
Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to DateIris Y Sheng, Moshe C Ornstein
Journal of Hematology|April 18, 2020
Infiltrative Rash Secondary to Leukemic-Phase Diffuse Large B-Cell Lymphoma With t(14;18), CDKN2A and MLL DeletionIris Y Sheng, Diana O Treaba, Kenneth D Bishop
Drugs in Context|April 2, 2021
Volume matters and intensification is needed: emerging trends in the management of advanced prostate cancerIris Y Sheng, Pedro Barata, Raafat Alameddine, et al.
Expert Review of Anticancer Therapy|June 9, 2020
Non-metastatic castration-resistant prostate cancer: current status and future directionsRuby Gupta, Iris Y Sheng, Pedro C Barata, et al.
Case Reports in Oncological Medicine|July 9, 2019
Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)Iris Y Sheng, Megan Kruse, Kathryn M Leininger, et al.
The Oncologist|October 1, 2025
A single-institution study evaluating the fertility of young adults with malignancy treated with immunotherapyJenny D Gong, Kathryn Coyne, Matthew Mirsky, et al.
Drugs in Context|June 29, 2026
Perioperative immune-checkpoint inhibitors for muscle-invasive bladder cancerAlbert Jang, Abby L Grier, Iris Y Sheng, et al.
Journal of Pediatric Ophthalmology and Strabismus|July 15, 2014
Feasibility of retinal screening in a pediatric population with type 1 diabetes mellitusAnton M Kolomeyer, Natasha V Nayak, Melissa A Simon, et al.
Clinical Genitourinary Cancer|August 18, 2020
Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage MigrationIris Y Sheng, Wei Wei, Yu-Wei Chen, et al.
Pageof 3